bluebird bio, Inc. — Form D

bluebird bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-19. The offering totals $47.4M, of which $29.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
James A GeraghtyDirectorLexington, MA
Geert-Jan A MulderDirectorCambridge, MA
Nick LeschlyDirectorCambridge, MA
Nick LeschlyExecutive OfficerCambridge, MA
Steven GillisDirectorSouth San Francisco, CA
Chip BairdExecutive OfficerNew York, NY
Robert TepperDirectorCambridge, MA
Denice R TorresDirectorCAMBRIDGE, MA
William R SellersDirectorCAMBRIDGE, MA
Daniel S LynchDirectorCambridge, MA
Jason ColeExecutive OfficerCambridge, MA
Mark R VachonDirectorCambridge, MA
John S AgwunobiDirectorCambridge, MA
Nick S LeschlyDirectorCambridge, MA
Nick S LeschlyExecutive OfficerCambridge, MA
Wendy S DixonDirectorCambridge, MA
Geert-Jan HC MulderDirectorWaltham, MA
Ramy S IbrahimDirectorCoral Gables, FL
Axel PolackDirectorCambridge, MA
Daniel S. LynchDirectorCambridge, MA
Jeffrey T. WalshExecutive OfficerCambridge, MA
John M. MaraganoreDirectorCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2021-09-21D$75.0M$75.0M
2012-07-25D$60.0M$60.0M
2011-04-27D$30.0M$15.0M
2011-04-27D/A$37.5M$37.5M

More